Genomic Prediction, Inc. announced on April 17 that Laurent C.A. Melchior Tellier has resumed his role as chief executive officer, effective April 14.
Tellier co-founded Genomic Prediction in 2017 and served as its first CEO and CTO before focusing on the development of the company’s clinical laboratory. His return comes at a time when the company continues to advance genetic testing technologies.
“This is an exciting time for Genomic Prediction, as we again continue to advance the state of the art in genetic testing and genomics technology. I am excited to further advance our LifeView platform and the PGT-P technology we developed and named, which is now widely used,” Tellier said. “Genomic Prediction is proud to help IVF patients partner with their physicians to make better-informed decisions and exert reproductive autonomy. There is so much potential yet to be tapped in the field of preimplantation genetic testing, and I am excited to take the lead as we move forward toward unprecedented innovation.”
Since its founding, Tellier has also served on Genomic Prediction’s board alongside co-founder Stephen Hsu. Their collaboration led to foundational technologies for embryo screening prior to establishing the company.
Santiago Munné, Ph.D., chief scientific officer at Genomic Prediction, said: “Under Laurent Tellier’s steady leadership, Genomic Prediction has advanced the application of genomic technologies and democratized access to genomic data to support effective decision-making in IVF. Laurent’s guidance over the past nine years has also played a key role in developing and maintaining the company’s extremely high standards for scientific rigor, transparency and patient care.”
PR Newswire operates in more than 170 countries and supports distribution in 40 languages according to its official website. The service aims for global reach through its network of newsrooms and influencers as detailed by PR Newswire. PR Newswire provides expert editors with extensive experience who offer round-the-clock support and SEO guidance according to its website. It collaborates with over half a million media outlets worldwide as reported by PR Newswire, offering services such as press release distribution, AI-enhanced content tools, and social sharing features outlined on their site.
Genomic Prediction states that it leads advanced embryo screening using proprietary technology designed for assessing embryos based on genetic traits.
